WO1990012086A1
(en)
*
|
1989-03-31 |
1990-10-18 |
Washington University |
Bordetella vaccines
|
US5637303A
(en)
*
|
1990-10-25 |
1997-06-10 |
Commonwealth Scientific And Industrial Research Organisation |
Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination
|
WO1992007582A1
(en)
*
|
1990-10-25 |
1992-05-14 |
Commonwealth Scientific And Industrial Research Organisation |
Corynebacteria and related organisms as vaccine vectors
|
AU666108B2
(en)
*
|
1990-11-09 |
1996-02-01 |
Washington University |
CDT mutants of salmonella typhi
|
US5843426A
(en)
*
|
1990-12-18 |
1998-12-01 |
The General Hospital Corporation |
Salmonella vaccines
|
US5599537A
(en)
*
|
1990-12-18 |
1997-02-04 |
The General Hospital Corporation |
Salmonella virulence genes
|
US6793927B1
(en)
*
|
1993-12-06 |
2004-09-21 |
The United States Of America As Represented By The Secretary Of The Department Of Agriculture |
Construction of Pasteurella haemolytica vaccines
|
US5587305A
(en)
*
|
1993-12-06 |
1996-12-24 |
The United States Of America As Represented By The Department Of Agriculture |
Pasteurella haemolytica transformants
|
US5922583A
(en)
*
|
1995-10-17 |
1999-07-13 |
Biostar Inc. |
Methods for production of recombinant plasmids
|
US5925354A
(en)
*
|
1995-11-30 |
1999-07-20 |
Michigan State University |
Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
|
US20030202980A1
(en)
*
|
1995-12-29 |
2003-10-30 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
ZA97452B
(en)
*
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
GB9615022D0
(en)
*
|
1996-07-17 |
1996-09-04 |
Mini Agriculture & Fisheries |
Vaccine preparations
|
US6020144A
(en)
|
1996-09-12 |
2000-02-01 |
Symbiontics, Inc. |
Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
|
CA2243730C
(en)
*
|
1997-07-29 |
2009-12-22 |
Akzo Nobel N.V. |
Streptococcus equi vaccine
|
AU750106B2
(en)
|
1997-10-07 |
2002-07-11 |
University Of Maryland Biotechnology Institute |
Method for introducing and expressing RNA in animal cells
|
US6024961A
(en)
|
1997-11-14 |
2000-02-15 |
Washington University |
Recombinant avirulent immunogenic S typhi having rpos positive phenotype
|
EP1051494B1
(en)
|
1998-01-31 |
2009-04-29 |
The University of Arkansas |
Methods and reagents for decreasing allergic reactions
|
US7879977B2
(en)
|
1998-01-31 |
2011-02-01 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
BR9908267A
(pt)
|
1998-02-27 |
2000-10-24 |
Univ Pennsylvania |
Plasmìdeo, composição farmacêutica, processos para induzir uma resposta imunológica em um indivìduo contra um imunógeno, para imunizar um indivìduo contra uma infecção por vìrus de herpes simples e para tratar um indivìduo que tem uma doença autoimune, vacina recombinante, e, patógeno atenuado vivo
|
US6713073B1
(en)
*
|
1998-07-24 |
2004-03-30 |
Megan Health, Inc. |
Method of vaccination of newly hatched poultry
|
JP2002531135A
(ja)
*
|
1998-12-04 |
2002-09-24 |
ユニヴァーシティ オブ マニトーバ |
クラミジア感染に対する2段階免疫感作法
|
AU774265B2
(en)
*
|
1999-03-03 |
2004-06-24 |
Trustees Of The University Of Pennsylvania, The |
Vaccines and gene therapy compositions and methods of making and using the same
|
BR0009663A
(pt)
|
1999-04-09 |
2002-04-09 |
Upjohn Co |
Composições de vacinas antibacterianas
|
US6790950B2
(en)
*
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
WO2000066162A1
(en)
*
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
US8153414B2
(en)
*
|
2000-04-06 |
2012-04-10 |
Allertein Therapeutics, Llc |
Microbial delivery system
|
US20050063994A1
(en)
*
|
2000-04-06 |
2005-03-24 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
US6780405B1
(en)
*
|
2000-04-28 |
2004-08-24 |
Avant Immunotherapeutics, Inc. |
Regulated antigen delivery system (RADS)
|
WO2002006303A2
(en)
*
|
2000-07-14 |
2002-01-24 |
The Trustees Of The University Of Pennsylvania |
Dna vaccines encoding hiv accessory proteins
|
AU2002211524B2
(en)
*
|
2000-10-04 |
2007-03-22 |
The Trustees Of The University Of Pennsylvania |
Highly expressible genes
|
US6872547B1
(en)
|
2000-10-11 |
2005-03-29 |
Washington University |
Functional balanced-lethal host-vector systems
|
US20040137003A1
(en)
*
|
2001-04-30 |
2004-07-15 |
Curtiss Iii Roy |
Regulated antigen delivery system (rads)
|
US8133493B2
(en)
*
|
2002-04-15 |
2012-03-13 |
Washington University |
Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
ATE535249T1
(de)
|
2003-06-13 |
2011-12-15 |
Univ Pennsylvania |
Vakzine, immuntherapeutika und verfahren zu ihrer verwendung
|
US20070087013A1
(en)
*
|
2003-12-09 |
2007-04-19 |
Donata Sizemore |
Orally-administered live bacterial vaccines for plague
|
WO2007050095A2
(en)
|
2004-11-19 |
2007-05-03 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines and methods for using the same
|
ATE533782T1
(de)
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
WO2007106073A2
(en)
|
2006-03-02 |
2007-09-20 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
DK3037429T3
(da)
*
|
2006-07-28 |
2019-01-21 |
Univ Pennsylvania |
Forbedrede hiv-vacciner
|
US20080124355A1
(en)
|
2006-09-22 |
2008-05-29 |
David Gordon Bermudes |
Live bacterial vaccines for viral infection prophylaxis or treatment
|
WO2009025888A2
(en)
|
2007-05-10 |
2009-02-26 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
|
EP2152883A4
(en)
*
|
2007-05-10 |
2010-10-27 |
Univ Arizona |
RECOMBINANT BACTERIA COMPRISING VECTORS FOR THE EXPRESSION OF NUCLEIC ACID SEQUENCES ENCODING ANTIGENS
|
WO2009046451A1
(en)
|
2007-10-05 |
2009-04-09 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting a protective immune response against c. perfringens
|
KR101589511B1
(ko)
*
|
2008-04-04 |
2016-02-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
치쿤구니야 바이러스 단백질의 공통 서열, 이를 인코딩하는 핵산 분자, 조성물 및 이를 이용하는 방법
|
US10071154B2
(en)
|
2008-04-04 |
2018-09-11 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
|
US8647642B2
(en)
|
2008-09-18 |
2014-02-11 |
Aviex Technologies, Llc |
Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
|
WO2010045620A1
(en)
|
2008-10-17 |
2010-04-22 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US8829174B2
(en)
|
2008-10-29 |
2014-09-09 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
JP5770711B2
(ja)
*
|
2009-03-23 |
2015-08-26 |
アンスティテュ パストゥール |
細胞中への免疫原性分子のデリバリーに適したCyaAポリペプチド突然変異体及びポリペプチド誘導体
|
US9163219B2
(en)
|
2009-04-14 |
2015-10-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Single expression vector for generation of a virus with a segmented genome
|
GB2483595B
(en)
|
2009-05-22 |
2017-03-29 |
The Arizona Board Of Regents For And On Behalf Of Arizona State Univ |
Recombinant bacterium and methods of antigen and nucleic acid delivery
|
US9045742B2
(en)
|
2009-05-29 |
2015-06-02 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant Edwardsiella bacterium
|
EP2477659A4
(en)
|
2009-09-14 |
2014-01-15 |
Univ Pennsylvania |
IMMUNOTHERAPEUTIC VACCINES AND AGENTS COMPRISING THE ALPHA IL-15 RECEPTOR AND / OR NUCLEIC ACID MOLECULES ENCODING THE SAME, AND METHODS OF USING THE SAME
|
CN106987595B
(zh)
|
2009-11-02 |
2021-07-06 |
宾夕法尼亚大学托管会 |
口蹄疫病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗
|
US9062297B2
(en)
|
2010-01-13 |
2015-06-23 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Yersinia pestis vaccine
|
US8889121B2
(en)
|
2010-01-22 |
2014-11-18 |
The Arizona Board Of Regents For An On Behalf Of Arizona State University |
Bacterium comprising a regulated rfaH nucleic acid
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
CN102781952B
(zh)
|
2010-02-08 |
2015-09-02 |
宾夕法尼亚大学托管会 |
编码rantes的核酸分子、包含其的组合物以及其使用方法
|
WO2011150421A2
(en)
|
2010-05-28 |
2011-12-01 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium to decrease tumor growth
|
WO2012003460A2
(en)
|
2010-07-02 |
2012-01-05 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Compositions and methods for bacterial lysis and neutral lipid production
|
BRPI1003750A2
(pt)
|
2010-07-22 |
2012-04-10 |
Univ Sao Paulo |
microrganismos recombinantes, métodos de preparação de linhagens vacinais, antìgenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia
|
KR101939150B1
(ko)
|
2010-11-12 |
2019-01-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
공통 전립선 항원, 이것을 암호화하는 핵산 분자, 그리고 이것을 포함하는 백신 및 용도
|
CN102140430B
(zh)
*
|
2011-01-13 |
2013-10-23 |
河南科技大学 |
一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
|
WO2012106377A2
(en)
|
2011-01-31 |
2012-08-09 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
|
EA037377B1
(ru)
|
2011-02-11 |
2021-03-22 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Вакцина для индукции иммунного ответа на hbv
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
WO2012123269A1
(en)
|
2011-03-11 |
2012-09-20 |
Proyecto De Biomedicina Cima, S.L. |
Immunogenic compositions and methods for their use
|
KR102071228B1
(ko)
|
2011-07-11 |
2020-01-30 |
이노비오 파마수티컬즈, 인크. |
교차-보호성 아레나바이러스 백신 및 이의 사용 방법
|
CN114277038A
(zh)
|
2011-10-12 |
2022-04-05 |
宾夕法尼亚大学理事会 |
用于人乳头状瘤病毒的疫苗及其使用方法
|
EP2771035B1
(en)
|
2011-10-24 |
2018-04-11 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
KR102674807B1
(ko)
|
2011-12-12 |
2024-06-13 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법
|
EP2791362B1
(en)
|
2011-12-12 |
2019-07-03 |
The Trustees Of The University Of Pennsylvania |
Proteins comprising mrsa pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat mrsa infections
|
AU2013245950B2
(en)
|
2012-04-10 |
2016-04-21 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
US9303264B2
(en)
|
2012-05-18 |
2016-04-05 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Photosynthetic microorganisms expressing thermostable lipase
|
KR101381793B1
(ko)
|
2013-02-27 |
2014-04-07 |
씨제이제일제당 (주) |
신규 박테리오파지 및 이를 포함하는 항균 조성물
|
KR20220140025A
(ko)
|
2013-03-12 |
2022-10-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
인간 파밀로마 바이러스용 개선된 백신 및 이것을 사용하는 방법
|
CN114225019A
(zh)
|
2013-03-15 |
2022-03-25 |
宾夕法尼亚大学理事会 |
癌疫苗及使用其的治疗方法
|
MX2015011487A
(es)
|
2013-03-15 |
2016-02-03 |
Univ Pennsylvania |
Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas.
|
US9580718B2
(en)
|
2013-06-17 |
2017-02-28 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Attenuated live bacteria with increased acid resistance and methods of use thereof
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
BR112020010499A2
(pt)
|
2017-12-13 |
2020-11-24 |
Inovio Pharmaceuticals, Inc. |
vacinas de câncer de alvo de mesotelina e usos das mesmas
|
CN117264963A
(zh)
|
2017-12-13 |
2023-12-22 |
艾诺奥医药品有限公司 |
靶向prame的癌症疫苗和其用途
|
MX2020006217A
(es)
|
2017-12-13 |
2020-12-03 |
Inovio Pharmaceuticals Inc |
Vacunas de cáncer dirigidas a muc16 y sus usos.
|